The LITE Study

Introduction The preliminary results of the LITE Study, a three-year trial focused on evaluating the efficacy of home phototherapy compared to in-office treatments, have been released. The data is promising for individuals seeking a safe and effective home treatment for plaque or guttate psoriasis. Dr. Joel Gelfand, the lead physician of the study, initiated this […]

Home Phototherapy for Psoriasis: Encouraging New Data, Optimizing Access

NatBio Secures Key Contract with Indiana University Health, Expanding Access to Home-Based Phototherapy

We’re excited to share that NatBio has secured a significant network contract with Indiana University Health (IUH), the largest healthcare system in Indiana. This new partnership allows IUH members and employees to use their private insurance plans to access NatBio’s FDA Class-II home phototherapy devices for conditions like psoriasis, vitiligo, and eczema. Darren Tuel, President […]

Psoriasis Awareness Month: The Benefits of Home Phototherapy

Introduction August marks Psoriasis Awareness Month, a dedicated time to shine a light on a condition that affects millions worldwide. Psoriasis is far more than just a skin issue; it’s a chronic autoimmune disease that can significantly impact one’s quality of life. At NatBio, we’re committed to advancing understanding and treatment options for this challenging […]

Psoriasis Treatment Algorithm Guided by Patients’ Preferences

The Sense of Stigmatization in Patients with Plaque Psoriasis

Stigmatization in Patients with Psoriasis: A Mini Review

Association of Noninfectious Pneumonia with Ustekinumab Use

Narrowband ultraviolet B phototherapy to clear and maintain clearance in patients with mycosis fungoides

A retrospective, descriptive study of patients with Mycosis fungoides treated by phototherapy (oral PUVA, NB-UVB) with a twice-weekly regimen with an experiential timeline of 13 years